Literature DB >> 24028907

Livedoid vasculopathy: an in-depth analysis using a modified Delphi approach.

Afsaneh Alavi1, Jürg Hafner, Jan P Dutz, Dieter Mayer, R Gary Sibbald, Paulo Ricardo Criado, Patricia Senet, Jeffery P Callen, Tania J Phillips, Marco Romanelli, Robert S Kirsner.   

Abstract

Livedoid vasculopathy (LV) is a noninflammatory thrombotic condition presenting in a primary idiopathic or secondary subtype associated with abnormal coagulation factors. Different from atrophie blanche (AB), which is a clinical manifestation of certain scars, LV may have AB in combination with recurrent livedo reticularis with chronic and painful skin ulcers particularly around the ankle region, and at the back of the feet. Histology is characterized by segmental hyalinizing changes at the subintimal region of small dermal vessels with thrombotic occlusions. LV skin ulcers resolve with stellate, porcelain-white scars that need to be distinguished from similar changes seen with venous insufficiency. "Atrophie blanche" was originally used synonymously with "livedoid vasculopathy." AB describes spontaneously occurring porcelain-white skin areas with red dots that typically occur in the context of skin changes attributed to chronic venous insufficiency. The 2 forms of AB--(1) the LV-AB complex and (2) AB in the context of chronic venous insufficiency--are unrelated and require separate diagnostic and therapeutic approaches. Using a modified Delphi method, we have developed an international consensus document on the diagnosis and management of LV. Individual sections of this document provide advice on diagnosis and management of LV.
Copyright © 2013 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.

Entities:  

Keywords:  AB; IVIG; LV; PAN; atrophie; atrophie blanche; blanche; coagulopathy; intravenous immunoglobulin; livedoid; livedoid vasculopathy; lower extremity; polyarteritis nodosa; vasculopathy

Mesh:

Year:  2013        PMID: 24028907     DOI: 10.1016/j.jaad.2013.07.019

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  11 in total

Review 1.  Vascular Manifestations in Antiphospholipid Syndrome (APS): Is APS a Thrombophilia or a Vasculopathy?

Authors:  Salma Siddique; Jessie Risse; Guillaume Canaud; Stéphane Zuily
Journal:  Curr Rheumatol Rep       Date:  2017-09-04       Impact factor: 4.592

2.  Exacerbation of livedoid vasculopathy after coronavirus disease 2019.

Authors:  Ryoko Kawabe; Kyoko Tonomura; Yorihisa Kotobuki; Ikuko Ueda-Hayakawa; Hiroyuki Murota; Manabu Fujimoto
Journal:  Eur J Dermatol       Date:  2022-01-01       Impact factor: 2.805

3.  Exacerbation of livedoid vasculopathy after coronavirus disease 2019.

Authors:  Ryoko Kawabe; Kyoko Tonomura; Yorihisa Kotobuki; Ikuko Ueda-Hayakawa; Hiroyuki Murota; Manabu Fujimoto
Journal:  Eur J Dermatol       Date:  2022-02-15       Impact factor: 2.805

4.  Therapeutic effect of autologous platelet-rich plasma (PRP) on recalcitrant cutaneous ulcers in livedoid vasculopathy.

Authors:  Tamihiro Kawakami; Sora Takeuchi; Tatsuro Okano; Hajime Inoue; Yoshinao Soma
Journal:  JAAD Case Rep       Date:  2015-08-25

5.  Successful treatment of livedoid vasculopathy with rivaroxaban.

Authors:  John M Evans; J Daniel Jensen; Naveed Sami
Journal:  JAAD Case Rep       Date:  2015-09-24

6.  Dermoscopic features of livedoid vasculopathy.

Authors:  Stephen Chu-Sung Hu; Gwo-Shing Chen; Chi-Ling Lin; Yang-Chun Cheng; Yung-Song Lin
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

Review 7.  Livedoid vasculopathy: A multidisciplinary clinical approach to diagnosis and management.

Authors:  Asli Bilgic; Salih Ozcobanoglu; Burcin Cansu Bozca; Erkan Alpsoy
Journal:  Int J Womens Dermatol       Date:  2021-09-02

Review 8.  Comparative Efficacy of Rivaroxaban and Immunoglobulin Therapy in the Treatment of Livedoid Vasculopathy: A Systematic Review.

Authors:  Shivana Ramphall; Swarnima Rijal; Vishakh Prakash; Heba Ekladios; Jiya Mulayamkuzhiyil Saju; Naishal Mandal; Nang I Kham; Rabia Shahid; Shaili S Naik; Sathish Venugopal
Journal:  Cureus       Date:  2022-08-27

9.  Exploring the risk factors for ischemic cerebrovascular disease in systemic lupus erythematosus: A single-center case-control study.

Authors:  Li Su; Zhigang Qi; Shaochen Guan; Lian Wei; Yi Zhao
Journal:  Front Immunol       Date:  2022-09-27       Impact factor: 8.786

Review 10.  Lessons from dermatology about inflammatory responses in Covid-19.

Authors:  Paulo Ricardo Criado; Carla Pagliari; Francisca Regina Oliveira Carneiro; Juarez Antonio Simões Quaresma
Journal:  Rev Med Virol       Date:  2020-07-12       Impact factor: 11.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.